Lactulose as a drug: quality and application spectrum
In humans, the gastrointestinal tract is a highly complex eco-system which reacts sensitively to its interior and exterior environment. An intact intestinal barrier, guarantees, together with a well functioning immune system, the integrity of the body's interior.
A number of influencing factors, such as stress, incorrect nutrition and lifestyle, as well as unusual hygienic conditions and food (e.g. on holiday) can upset this delicate system and lead to health difficulties. If used correctly, the prebiotic effect of lactulose can play a major role in ensuring that equilibrium is stabilized or re-established.
In human medicine, lactulose has a long track record as a successful therapy against constipation, portal hepatic encephalopathy and salmonella, or as a complementary measure.
Lactulose has been successfully applied in the treatment of constipation since 1959. Lactulose has proven its efficacy as a gentle as well as highly effective medication in the regulation of intestinal activity and regular bowels. It can also play an important role to support intestinal activities in the pre- and post-operative phases.
Golden Standard in Portal - Systemic Encephalopathy
Lactulose has been the Gold Standard in PSE therapy since 1966. Lactulose has an inhibiting action on ammonia production in the ileum and reduces the ammonia level in portal circulation.
Salmonella infections
Lactulose has been applied in the treatment of intestinal infections since 1975. Lactulose reduces the pH value to make the milieu less favourable for salmonella and expedites transit time. Both actions are important pre-conditions for the regeneration of intestinal flora.
